-
1
-
-
27244447048
-
Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia
-
Pession A, Valsecchi MG, Masera G, et al. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. J Clin Oncol. 2005;23:7161-7167.
-
(2005)
J Clin Oncol
, vol.23
, pp. 7161-7167
-
-
Pession, A.1
Valsecchi, M.G.2
Masera, G.3
-
2
-
-
0032973925
-
Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: A Pediatric Oncology Group study
-
Amylon MD, Shuster J, Pullen J, et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia. 1999;13:335-342.
-
(1999)
Leukemia
, vol.13
, pp. 335-342
-
-
Amylon, M.D.1
Shuster, J.2
Pullen, J.3
-
3
-
-
0000973839
-
Antibodies to asparaginase alter pharmacokinetics and decrease enzyme activity in patients on asparaginase theapy
-
Kurtzberg J, Asselin B, Poplack D, et al. Antibodies to asparaginase alter pharmacokinetics and decrease enzyme activity in patients on asparaginase theapy. Proc Annu Meet Am Assoc Cancer Res. 1993;34:A1807.
-
(1993)
Proc Annu Meet Am Assoc Cancer Res
, vol.34
-
-
Kurtzberg, J.1
Asselin, B.2
Poplack, D.3
-
4
-
-
0021032126
-
Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia
-
Sallan SE, Hitchcock-Bryan S, Gelber R, et al. Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia. Cancer Res. 1983;43:5601-5607.
-
(1983)
Cancer Res
, vol.43
, pp. 5601-5607
-
-
Sallan, S.E.1
Hitchcock-Bryan, S.2
Gelber, R.3
-
5
-
-
0027197614
-
Comparative pharmacokinetic studies of three asparaginase preparations
-
Asselin BL, Whitin JC, Coppola DJ, et al. Comparative pharmacokinetic studies of three asparaginase preparations. J Clin Oncol. 1993;11:1780-1786.
-
(1993)
J Clin Oncol
, vol.11
, pp. 1780-1786
-
-
Asselin, B.L.1
Whitin, J.C.2
Coppola, D.J.3
-
6
-
-
2442496750
-
Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961
-
Panosyan EH, Seibel NL, Martin-Aragon S, et al. Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961. J Pediatr Hematol Oncol. 2004;26: 217-226.
-
(2004)
J Pediatr Hematol Oncol
, vol.26
, pp. 217-226
-
-
Panosyan, E.H.1
Seibel, N.L.2
Martin-Aragon, S.3
-
7
-
-
84863116322
-
Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia
-
Kawedia JD, Liu C, Pei D, et al. Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia. Blood. 2012;119:1658-1664.
-
(2012)
Blood
, vol.119
, pp. 1658-1664
-
-
Kawedia, J.D.1
Liu, C.2
Pei, D.3
-
8
-
-
0034117076
-
Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia
-
Woo MH, Hak LJ, Storm MC, et al. Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol. 2000;18:1525-1532.
-
(2000)
J Clin Oncol
, vol.18
, pp. 1525-1532
-
-
Woo, M.H.1
Hak, L.J.2
Storm, M.C.3
-
9
-
-
0037085747
-
A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: A Children's Cancer Group study
-
Avramis VI, Sencer S, Periclou AP, et al. A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood. 2002;99:1986-1994.
-
(2002)
Blood
, vol.99
, pp. 1986-1994
-
-
Avramis, V.I.1
Sencer, S.2
Periclou, A.P.3
-
10
-
-
0035018209
-
Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemia
-
Vieira Pinheiro JP, Muller HJ, Schwabe D, et al. Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemia. Br J Haematol. 2001;113:115-119.
-
(2001)
Br J Haematol
, vol.113
, pp. 115-119
-
-
Vieira Pinheiro, J.P.1
Muller, H.J.2
Schwabe, D.3
-
11
-
-
0018617937
-
Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia
-
Nesbit M, Chard R, Evans A, et al. Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia. Am J Pediatr Hematol Oncol. 1979; 1:9-13.
-
(1979)
Am J Pediatr Hematol Oncol
, vol.1
, pp. 9-13
-
-
Nesbit, M.1
Chard, R.2
Evans, A.3
-
12
-
-
0036163591
-
PEG-asparaginase (Oncaspar) 2500 U/m(2) BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols
-
Muller HJ, Beier R, da Palma JC, et al. PEG-asparaginase (Oncaspar) 2500 U/m(2) BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols. Cancer Chemother Pharmacol. 2002;49:149-154.
-
(2002)
Cancer Chemother Pharmacol
, vol.49
, pp. 149-154
-
-
Muller, H.J.1
Beier, R.2
Da Palma, J.C.3
-
13
-
-
0033836246
-
Pegylated asparaginase (Oncaspar) in children with ALL: Drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols
-
Muller HJ, Loning L, Horn A, et al. Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols. Br J Haematol. 2000;110:379-384.
-
(2000)
Br J Haematol
, vol.110
, pp. 379-384
-
-
Muller, H.J.1
Loning, L.2
Horn, A.3
-
14
-
-
77949895397
-
Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia
-
Silverman LB, Supko JG, Stevenson KE, et al. Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia. Blood. 2010;115:1351-1353.
-
(2010)
Blood
, vol.115
, pp. 1351-1353
-
-
Silverman, L.B.1
Supko, J.G.2
Stevenson, K.E.3
-
15
-
-
0022443776
-
Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia
-
Clavell LA, Gelber RD, Cohen HJ, et al. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J Med. 1986;315: 657-663.
-
(1986)
N Engl J Med
, vol.315
, pp. 657-663
-
-
Clavell, L.A.1
Gelber, R.D.2
Cohen, H.J.3
-
16
-
-
0028204905
-
Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01
-
Schorin MA, Blattner S, Gelber RD, et al. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01. J Clin Oncol. 1994;12:740-747.
-
(1994)
J Clin Oncol
, vol.12
, pp. 740-747
-
-
Schorin, M.A.1
Blattner, S.2
Gelber, R.D.3
-
17
-
-
0034284267
-
Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: A Pediatric Oncology Group Study
-
Abshire TC, Pollock BH, Billett AL, et al. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Blood. 2000;96:1709-1715.
-
(2000)
Blood
, vol.96
, pp. 1709-1715
-
-
Abshire, T.C.1
Pollock, B.H.2
Billett, A.L.3
-
18
-
-
0017360242
-
L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia
-
Ortega JA, Nesbit ME Jr., Donaldson MH, et al. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia. Cancer Res. 1977;37:535-540.
-
(1977)
Cancer Res
, vol.37
, pp. 535-540
-
-
Ortega, J.A.1
Nesbit Jr., M.E.2
Donaldson, M.H.3
-
19
-
-
0020080755
-
Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma
-
Evans WE, Tsiatis A, Rivera G, et al. Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma. Cancer. 1982;49:1378-1383.
-
(1982)
Cancer
, vol.49
, pp. 1378-1383
-
-
Evans, W.E.1
Tsiatis, A.2
Rivera, G.3
-
20
-
-
0022982465
-
Antibody response to Escherichia coli L-asparaginase. Prognostic significance and clinical utility of antibody measurement
-
Cheung NK, Chau IY, Coccia PF. Antibody response to Escherichia coli L-asparaginase. Prognostic significance and clinical utility of antibody measurement. Am J Pediatr Hematol Oncol. 1986;8:99-104.
-
(1986)
Am J Pediatr Hematol Oncol
, vol.8
, pp. 99-104
-
-
Cheung, N.K.1
Chau, I.Y.2
Coccia, P.F.3
-
21
-
-
0017177135
-
Comparison of anaphylactic reactions to asparaginase derived from Escherichia coli and from Erwinia cultures
-
Dellinger CT, Miale TD. Comparison of anaphylactic reactions to asparaginase derived from Escherichia coli and from Erwinia cultures. Cancer. 1976;38:1843-1846.
-
(1976)
Cancer
, vol.38
, pp. 1843-1846
-
-
Dellinger, C.T.1
Miale, T.D.2
-
22
-
-
33947600985
-
Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia
-
Douer D, Yampolsky H, Cohen LJ, et al. Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia. Blood. 2007;109: 2744-2750.
-
(2007)
Blood
, vol.109
, pp. 2744-2750
-
-
Douer, D.1
Yampolsky, H.2
Cohen, L.J.3
-
23
-
-
32544457262
-
A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia
-
Rizzari C, Citterio M, Zucchetti M, et al. A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia. Haematologica. 2006;91:24-31.
-
(2006)
Haematologica
, vol.91
, pp. 24-31
-
-
Rizzari, C.1
Citterio, M.2
Zucchetti, M.3
-
24
-
-
84885181101
-
Randomized Comparison of IV PEG and im e coli asparaginase in children and adolescents with acute lymphoblastic leukemia: Results of the DFCI ALL Consortium Protocol 05-01
-
Silverman LB, Stevenson K, Vrooman LM, et al. Randomized Comparison of IV PEG and IM E. coli asparaginase in children and adolescents with acute lymphoblastic leukemia: results of the DFCI ALL Consortium Protocol 05-01. ASH Annual Meeting Abstracts. 2011;118:874.
-
(2011)
ASH Annual Meeting Abstracts
, vol.118
, pp. 874
-
-
Silverman, L.B.1
Stevenson, K.2
Vrooman, L.M.3
-
25
-
-
0026684162
-
Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase
-
Billett AL, Carls A, Gelber RD, et al. Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase. Cancer. 1992;70:201-206.
-
(1992)
Cancer
, vol.70
, pp. 201-206
-
-
Billett, A.L.1
Carls, A.2
Gelber, R.D.3
-
26
-
-
0031681258
-
Anti-asparaginase antibodies following e coli asparaginase therapy in pediatric acute lymphoblastic leukemia
-
Woo MH, Hak LJ, Storm MC, et al. Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia. Leukemia. 1998;12:1527-1533.
-
(1998)
Leukemia
, vol.12
, pp. 1527-1533
-
-
Woo, M.H.1
Hak, L.J.2
Storm, M.C.3
-
27
-
-
0017253880
-
Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia
-
Killander D, Dohlwitz A, Engstedt L, et al. Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia. Cancer. 1976;37:220-228.
-
(1976)
Cancer
, vol.37
, pp. 220-228
-
-
Killander, D.1
Dohlwitz, A.2
Engstedt, L.3
-
28
-
-
0031893235
-
Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia
-
Larson RA, Fretzin MH, Dodge RK, et al. Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia. Leukemia. 1998;12:660-665.
-
(1998)
Leukemia
, vol.12
, pp. 660-665
-
-
Larson, R.A.1
Fretzin, M.H.2
Dodge, R.K.3
-
29
-
-
34548387897
-
Allergic reactions to E. Coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: A Children's Oncology Group Study
-
Wacker P, Land VJ, Camitta BM, et al. Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study. J Pediatr Hematol Oncol. 2007;29: 627-632.
-
(2007)
J Pediatr Hematol Oncol
, vol.29
, pp. 627-632
-
-
Wacker, P.1
Land, V.J.2
Camitta, B.M.3
-
30
-
-
0035283163
-
Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber Consortium Protocol 91-01
-
Silverman LB, Gelber RD, Dalton VK, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood. 2001;97:1211-1218.
-
(2001)
Blood
, vol.97
, pp. 1211-1218
-
-
Silverman, L.B.1
Gelber, R.D.2
Dalton, V.K.3
|